My research interests include skin and allergy problems diagnosed and managed in primary care, mainly focusing on childhood eczema

Current projects include:

• TOPIC (Transforming Outcomes for Paediatric allergy In primary Care): a programme of work to transform the treatment of eczema, and research into food allergy and its prevention, in children.
• TIGER (Trial of food allergy (IgE) tests for Eczema Relief): Pragmatic, primary care, multi-centre, individually randomised trial to determine the clinical and cost effectiveness of test-guided dietary advice versus standard care, for the management of eczema.
• ATHENA (Amitriptyline for the prevention of post-herpetic neuralgia): multi-centre, individually randomised, pragmatic, placebo-controlled superiority trial to determine the clinical and cost effectiveness of prophylactic low-dose amitriptyline for the prevention of post-herpetic neuralgia.
• RAPID eczema trials: A project working with members of the public to prioritise, design and conduct high-quality online trials to test different ways of managing eczema.
• ACO (Acne Care Online): a programme of research to create and test an online toolkit to support young people effectively treat their acne.
• DEXACELL (Dexamethasone as an adjunctive therapy for the management of cellulitis)
• CORAL (The effectiveness and cost effectiveness of coenzyme Q10 in heart failure with reduced ejection fraction): a pragmatic, patient-centred, data-enabled trial in primary care. 

Examples of recently completed research are: 

• BEE (Best Emollients for Eczema): Pragmatic, primary care, multi-centre, individually randomised superiority trial of four emollients in children with eczema
• TEST (Trial of Eczema allergy Screening Tests): feasibility randomised controlled trial with economic scoping and nested qualitative study
• Eczema Care Online (ECO): Supporting self-care for eczema in the community
• Spironolactone for Adult Female Acne (SAFA): pragmatic multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone for moderate or severe persistent acne in women
• RAPID-TEST: Rapid respiratory microbiological point-of-care-testing in primary care: a randomised controlled trial with internal pilot and qualitative and quantitative investigation of microbial, behavioural and antibiotic mechanisms.
• Talking in Primary Care 2: Testing the effects of communication skills e-learning for practitioners on patients’ musculoskeletal pain and enablement.
• ATLANTIS (Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment): a double-blind placebo-controlled trial
• TRIUMPH (TReating Urinary symptoms in Men in Primary Healthcare using non-pharmaceutical and non-surgical interventions)
• Surgical interventions to treat severe pressure sores (SiPS)